Table 4.

Effects of rosiglitazone treatment on serum concentrations of lipocalin-2 and several other metabolic and inflammatory parameters in 32 T2DM patients (21 male and 11 female).

Baseline8 weeks
Age, years55.4 (9.8)
BMI, kg/m225.4 (3.6)25.5 (3.6)
Waist circumference, cm86.8 (10.1)86.9 (10.3)
Triglycerides, mmol/L1.7 (1.0)1.8 (1.1)
Fasting glucose, mmol/L8.7 (1.5)6.8 (1.2)1
Fasting insulin, mIU/L10.2 (5.0)7.9 (3.5)2
HOMA-IR4.0 (2.2)2.4 (1.2)1
CRP, mg/L2.0 (1.9)1.2 (1.3)1
Serum adiponectin, mg/L7.7 (5.5)17.1 (13.0)1
Lipocalin 2, μg/L84.8 (25.2)57.1 (22.0)1